Uncovering genomic causes of co-morbidity in epilepsy: gene-driven phenotypic characterization of rare microdeletions
- PMID: 21858020
- PMCID: PMC3157359
- DOI: 10.1371/journal.pone.0023182
Uncovering genomic causes of co-morbidity in epilepsy: gene-driven phenotypic characterization of rare microdeletions
Abstract
Background: Patients with epilepsy often suffer from other important conditions. The existence of such co-morbidities is frequently not recognized and their relationship with epilepsy usually remains unexplained.
Methodology/principal findings: We describe three patients with common, sporadic, non-syndromic epilepsies in whom large genomic microdeletions were found during a study of genetic susceptibility to epilepsy. We performed detailed gene-driven clinical investigations in each patient. Disruption of the function of genes in the deleted regions can explain co-morbidities in these patients.
Conclusions/significance: Co-morbidities in patients with epilepsy can be part of a genomic abnormality even in the absence of (known) congenital malformations or intellectual disabilities. Gene-driven phenotype examination can also reveal clinically significant unsuspected condition.
Conflict of interest statement
Figures
References
-
- Gaitatzis A, Carroll K, Majeed A, W Sander J. The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia. 2004;45:1613–1622. - PubMed
-
- Winawer MR, Hesdorffer DC. Migraine, epilepsy, and psychiatric comorbidity: partners in crime. Neurology. 2010;74:1166–1168. - PubMed
-
- Zaccara G. Neurological comorbidity and epilepsy: implications for treatment. Acta Neurol Scand. 2009;120:1–15. - PubMed
